Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes
Justin Reese, Jasmin Divers(Wake Forest University), Blessy Antony(Virginia Tech), Hemalkumar B. Mehta, G. Caleb Alexander, Yun Jae Yoo(Stony Brook University), Johanna Loomba(University of Virginia), Hannah Blau(Jackson Laboratory), Joseph E Flack, David Sahner(American Axle & Manufacturing (United States)), Richard A. Moffitt(University of Iowa), Tiffany J. Callahan(Columbia University Irving Medical Center), Peter N. Robinson(Max Planck Institute for Molecular Genetics), Luca Cappelletti(University of Milan), J. Harry Caufield(Lawrence Berkeley National Laboratory), Shyam Visweswaran, Corneliu Antonescu(University of Arizona), Guy Karlebach(Jackson Laboratory), Jineta Banerjee(Sage Bionetworks), Feifan Liu(Yunnan University), Hannah Davis(Patient-Led Research Collaborative), Heidi Spratt(The University of Texas Medical Branch at Galveston), Julie A. McMurry(Oregon State University), Michael Gargano(XLAB (Slovenia)), Davera Gabriel(Johns Hopkins University), Tommaso Fontana(University of Milan), Elaine Hill(University of Rochester Medical Center), Robert Miller, Christopher G. Chute(University of Victoria), Kristin Kostka(Nuffield Orthopaedic Centre), Melissa Haendel(University of Colorado Hospital), Giorgio Valentini(University of Milan), T. M. Murali(Virginia Tech), Charisse Madlock‐Brown(University of Tennessee Health Science Center), Elena Casiraghi(Lawrence Berkeley National Laboratory), Lorna E. Thorpe(New York University), Kenneth J. Wilkins(National Institutes of Health), Rachel Wong, Ben Coleman(Jackson Laboratory), Nariman Ammar(University of Tennessee Health Science Center), Timothy Bergquist(Sage Bionetworks), Bryan Laraway(University of Colorado Anschutz Medical Campus), Andrew E. Williams(Tufts Medical Center), Anthony Solomonides(NorthShore University HealthSystem)
Cited by 176
Related Papers
Long COVID: major findings, mechanisms and recommendations
|Nature Reviews Microbiology|2023|4k
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact
|EClinicalMedicine|2021|2.9k
BioPortal: ontologies and integrated data resources at the click of a mouse
|Nucleic Acids Research|2009|884
MYH9 is associated with nondiabetic end-stage renal disease in African Americans
|Nature Genetics|2008|646